US20040003818A1 - Minimally light reflective surgical drape - Google Patents

Minimally light reflective surgical drape Download PDF

Info

Publication number
US20040003818A1
US20040003818A1 US10/385,981 US38598103A US2004003818A1 US 20040003818 A1 US20040003818 A1 US 20040003818A1 US 38598103 A US38598103 A US 38598103A US 2004003818 A1 US2004003818 A1 US 2004003818A1
Authority
US
United States
Prior art keywords
surgical drape
drape
surface
polymeric film
nm
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/385,981
Inventor
David Padget
Leland Annett
Timothy Smalstig
Original Assignee
Padget David B.
Annett Leland W.
Smalstig Timothy P.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US09/975,646 priority Critical patent/US6530376B1/en
Application filed by Padget David B., Annett Leland W., Smalstig Timothy P. filed Critical Padget David B.
Priority to US10/385,981 priority patent/US20040003818A1/en
Publication of US20040003818A1 publication Critical patent/US20040003818A1/en
Priority claimed from US11/752,107 external-priority patent/US20080078413A1/en
Application status is Abandoned legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B46/00Surgical drapes
    • A61B46/40Drape material, e.g. laminates; Manufacture thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B46/00Surgical drapes

Abstract

A surgical drape manufactured or fabricated from a polymeric film having a low glare finish and a predetermined coloration for reducing the luminous intensity of light reflected from the surface thereof is provided. Such surgical drape thereby minimizes reflectivity therefrom, and thus eye strain and fatigue. The subject invention includes the use of colorants, dyes, pigments, etc. to form translucent polymeric surgical drapes that absorb a selected range of wavelengths from surface reflected light. More particularly, the use of coloring agents in combination with a textured surface yield a surgical drape possessing reduced luminance and glare, thereby mitigating eye strain and fatigue. The preferred range of reflected light, in order of preference, is 625-700 nm, 520-560 nm, 450-520 nm, 400-450 nm, 600-625 nm, and 560-600 nm.

Description

    TECHNICAL FIELD
  • The present invention relates to surgical drapes, and more particularly to surgical drapes formed from a polymeric film having a low glare finish and a predetermined coloration for selectively reducing the luminous intensity of light reflected from the surface thereof. [0001]
  • BACKGROUND OF INVENTION
  • The complete visual system requires light, the eye, and a conscious observer. The visual system is especially well adapted for rapid and precise visual extraction of spatial information from a more or less remote external world, doing so by analysis of the continuously changing patterns of radiant flux impinging upon the surfaces of the eyes. Much of this light is reflected from objects which must be discriminated, recognized, attended to, and/or avoided in the environment, all the while transcending enormous variations in intensity, quality and geometry of illumination as well as the vantage point of the observer. [0002]
  • Light (i.e., visible light) represents only one portion of the electromagnetic spectrum, namely the portion laying between radio waves and x-rays, more particularly those electromagnetic waves possessing a wavelength between about 380-770 nanometers (nm). The lighting or illumination of a surface is the luminous flux which it receives per unit area (i.e., luminous flux is a measure of the power of visible light). Common units for luminous flux (i.e., illuminance) include the foot-candle (i.e., 1 lumen per square foot, or the foot lambert), and the lux (i.e., 1 lumen per square meter). Minimum recommended task based lighting levels are provided by General Electric Company as follows: casual, 30 footcandles (fc); rough, 50 fc; medium, 100 fc; fine, 500 fc; and, extra-fine, 1,000 fc. [0003]
  • Color is a characteristic of light that produces specific degrees of hue, saturation and brightness, with most color models of perceived color containing these three components. For instance, in the International Commission on Illumination (CIE) “L*a*b model”, color is modeled as a sphere, with lightness comprising the linear transformation from white to black, and hues modeled as opposing pairs, with saturation being the distance from the lightness axis. [0004]
  • Chromaticity (i.e., apparent color temperature or correlated color temperature) is the measure of a light source's “warmth” or “coolness,” expressed in the Kelvin (°K) temperature scale. It describes the appearance an object would have if it were heated to incandescence (i.e., the point of emitting light) then to higher temperatures where the appearance changes from ruddy red through a range of warm colors to white, then finally to blue-white. Selected sources of illumination and their color temperatures include: candle flame, 1850° K; sunlight (sunrise/set), 2000° K; sunlight (mean noon), 5400° K; 40 watt incandescent tungsten lamp, 2650° K; 100 watt incandescent tungsten lamp, 2865° K; 500 watt incandescent tungsten lamp, 2960° K; photoflood/reflector flood, 3400° K; white flame carbon arc lamp, 5000° K; and, xenon arc lamp, 6420° K. [0005]
  • The human eye includes various muscles which, like any part of the human body, will tire and strain when kept in a fixed configuration for sufficiently long periods. Immediate symptoms of eye fatigue and eye strain include headaches and difficulty focusing one's vision. In the long term, prolonged or severe eye fatigue and strain may decrease the strength of eye muscles and require corrective lenses, or an increased prescription for those already requiring corrective lenses. [0006]
  • When an object is too close to a viewer, the viewer is forced to bring his or her eyes inward (i.e., towards their nose). The motion of the eyes turning inward is called convergence. Convergence requires intensive exertion of the eye muscles, in particular the ocular muscles. When the eyes are not properly relaxed through either visual exercise or rest, the viewer may experience eye fatigue and/or eye strain. [0007]
  • Repeated and/or prolonged convergence can permanently decrease the strength of the eye muscles. [0008]
  • In addition, a viewer's eyes must focus in order to properly perceive an object. Focusing causes strain to the viewer's eyes. In order to focus on close objects, the eye's lens thickens. That is, the closer an object to the viewer, the thicker the eye's lens must shape themselves. Thickening the eye's lens is particularly exhausting on the eye muscles, serving to exacerbate the fatigue and strain brought on by the convergence that also accompanies viewing close objects. [0009]
  • One result of eye fatigue and eye strain is a diminished synchronization between a viewer's pair of eyes. That is, the viewer's left and right eyes are not working synchronously to provide the visual information required to visually perceive one's surroundings. Accordingly, common orthoptic tests involve monitoring the eye's ability to synchronize, while common orthoptic treatments involve the viewer performing eye exercises that promote synchronization, either through stretching and strengthening the eye muscles, or via forced relaxation. [0010]
  • Some of the most common causes of eye fatigue and/or strain include viewing close objects, viewing objects displayed on a light emitting medium, and simply viewing images for excessive time periods. Reading or doing close work in extreme light conditions, whether bright or dim, for extended periods forces the eyes to focus under less than optimal conditions, and thereby contributes to eye strain, symptoms of which may include; headaches; blurred vision; pain or soreness of the eyeball; red/watery eyes; dry eyes that feel scratchy; tired, aching heaviness of the eyelids or forehead; back and neck aches; and, muscle spasms. [0011]
  • Glare is a similar phenomenon which contributes to eye strain, in addition to mitigating visual acuity. The contrast between the image being viewed and its background is reduced by reflected light, making it harder for the brain to interpret the image. Facial and eye muscles tighten as the eye unconsciously strains to send a clear signal to the brain. [0012]
  • A particularly harsh visual system setting, or environment, for the eyes is a hospital operating room. In addition to the requirements of up-close high precision work, which in and of itself is stressful, high intensity surgical lighting systems are present to aid the surgeon and his or her team. Such lighting systems are known to deliver up to, and in excess of 140,000 lux (i.e., lumens per square meter, or about 13,000 fc) at about 4500° K chromaticity. Working for long periods of time, anywhere from one to eight plus hours per procedure, under such light conditions is more often than not the cause of eye fatigue and/or strain. Alleviation or mitigation of the source of such stress to the visual system would be most welcome. Such improved working conditions, as minimal as they might seem, may be of paramount importance to those who rely upon the skill and execution of the surgeon. [0013]
  • SUMMARY OF THE INVENTION
  • A surgical drape manufactured or fabricated from a polymeric film having a low glare finish and a predetermined coloration for reducing the luminous intensity of light reflected from the surface thereof is provided. Such surgical drape thereby minimizes reflectivity therefrom, and thus eye strain and fatigue. The subject invention includes the use of colorants, dyes, pigments, etc. to form translucent polymeric surgical drapes that absorb a selected range of wavelengths from surface reflected light. Furthermore, the subject invention includes such energy absorbing drape having a textured surface to effectuate a reduced reflectivity. More particularly, the use of coloring agents in combination with a textured surface yield a surgical drape possessing reduced luminance and glare, thereby mitigating eye strain and fatigue. The preferred range of reflected light, in order of preference, is 625-700 nm, 520-560 nm, 450-520 nm, 400-450 nm, 600-625 nm, and 560-600 nm. More specific features and advantages will become apparent with reference to the DETAILED DESCRIPTION OF THE INVENTION, appended claims, and the accompanying drawing figures.[0014]
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1 is a plan view of a surgical drape of the subject invention, more particularly an ocular drape; [0015]
  • FIG. 2 is a side or edge view of the surgical drape of FIG. 1; [0016]
  • FIG. 3 is a tabulation of Test No. 1 data, namely average gloss values, as a function of geometry, for each of the test drape samples; [0017]
  • FIG. 4 is a graph of the average gloss values at an 85° geometry recorded for each of the test drape samples of the table of FIG. 3; [0018]
  • FIG. 5 is a tabulation of Test No. 2 data, namely average gloss values, as a function of geometry, for each of the test drape samples; [0019]
  • FIG. 6 is a graph of the average gloss values at an 85° geometry recorded for each of the test drape samples of the table of FIG. 5; [0020]
  • FIG. 7 is a tabular summary of statistical parameters associated with the obtained gloss data; [0021]
  • FIG. 8 is a tabular comparison of t-Test results for the drape of the subject invention and the benchmark drape; [0022]
  • FIG. 9 is a graph depicting the average (mean) gloss values at an 95% confidence interval recorded for each of the test drape samples of the table of FIG. 7; [0023]
  • FIG. 10 is a graph depicting the standard deviation of the gloss values recorded for each of the test drape samples of the table of FIG. 7; [0024]
  • FIG. 11 is a tabulation of luminance, as a function of drape finish, for each of the test drape samples; and, FIG. 12 is a graphic representation of the data of FIG. 11.[0025]
  • DETAILED DESCRIPTION OF THE INVENTION
  • Referring to FIGS. 1 and 2, there is shown a surgical drape [0026] 10, more particularly an ophthalmic incise drape, having a perimeter edge 12, an adhesive patch 14, and a drain port assembly 16. These figures are provided to illustrate one embodiment of the subject invention. Although an ophthalmic drape is shown, it is to be understood that the present invention is not so limited, with any drape style or configuration being formed, treated, otherwise manufactured, etc., as is known to those of skill in the pertinent art, so as to reduce eye strain consistent with the invention of the subject disclosure. Drape styles suitable for the practice of the subject invention include, but are not limited to, those disclosed in U.S. Pat. Nos. 4,745,915 and 6,102,044, each of which being incorporated herein by reference.
  • The subject invention includes the use of colorants, dyes, pigments, etc. to form translucent polymeric surgical drapes that absorb a selected range of wavelengths from surface reflected light. Furthermore, the subject invention includes such energy absorbing drape having a textured surface to effectuate a reduced reflectivity. More particularly, the use of coloring agents in combination with a textured surface yield a drape possessing reduced luminance and glare, thereby mitigating eye strain and fatigue. Test results, which are discussed hereinafter, indicate that the preferred range of reflected light be, in order of preference, 625-700 nm, 520-560 nm, 450-520 nm, 400-450 nm, 600-625 nm, and 560-600 nm. [0027]
  • Colored drape line testing was conducted to demonstrate the reduction in both glare and light reflection utilizing the colored polyethylene surgical drapes. Both specular gloss testing, illuminance, and chromaticity testing was completed. A discussion of each methodology and the results obtained follows. [0028]
  • Specular Gloss Testing [0029]
  • Specular gloss testing was performed in accordance with ASTM Standard D523-89, which is incorporated herein by reference, on differing polyethylene drape materials. A specular gloss test measures the capacity of a surface to reflect more light in one direction than in others. The main factors that affect the reflection of light from a surface are the haziness of the material and the texture of the surface. The specular gloss test is performed using an apparatus that consists of an incandescent light source and a photo detector. The angle of the incident light is measured from the perpendicular of the material surface. The photo detector is placed at the mirror/image position of the light source. Measurements of the luminous flux are taken at 85°, 60°, and 20° geometries. The values that are obtained from the measurements are the relative luminous reflectance factor (RLRF). The RLRF is the ratio of the luminous flux from the surface being tested to the luminous flux of a standard polished glass mounted on a black surface measured at the same angle. [0030]
  • Since the results from this test are mainly affected by the surface finish of material, it is expected that the difference between specular gloss readings for the benchmark drapes (i.e., a Minnesota Mining & Manufacturing, Inc. model No. 1060 (hereinafter 3M® 1060), and a Medical Concepts Design Inc., model No. D1060 (hereinafter MCD D1060)) to be greater than the difference between the colored drape materials. This is primarily due to the fact that the surface finish of the benchmark drapes are different. The difference in the specular gloss readings between the colored drapes and the MCD D1060 drape should not be as great since they have a similar surface finish. The MCD D1060 drape and the colored drape should have lower specular gloss numbers since, when observed visually, they appear to have much less glare than the 3M® 1060 drape. [0031]
  • In a first study (i.e., Test No. 1), nine different drape samples were tested, and ten readings were taken for each drape sample. The results of the testing are presented in FIGS. 3 and 4. [0032]
  • Section 4 of ASTM D523 indicates that an 85° geometry is the most useful for comparing different specimens when the gloss value at 60° is less than 10. The graph of FIG. 4 shows the average gloss values for each specimen at a 85° geometry. The graph of FIG. 4 also has standard deviation bars of ±σ centered on the average value. From this graph, it can be seen that the benchmark MCD D1060 drape and the colored drapes, which have a similar surface texture, are all within a narrow range of values (1.7-3.8). The benchmark 3M® 1060 drape is outside the aforementioned range (5.6), indicating that its gloss value was significantly higher than that of the benchmark MCD D1060 drape. [0033]
  • A second specular gloss study (i.e., Test No. 2) was performed using those drape colors which yielded the lowest average gloss value in the first study. Also included were the benchmark MCD D1060 and the benchmark 3M® 1060 drape for comparison. In the second study, two different samples of each drape material were tested and the measurements were all taken on the matte finish side. The results are presented in FIGS. 5 and 6. [0034]
  • Once again, the values of the 60° geometry were below 10, so the 85° geometry values were used for the comparison purposes. The graph of FIG. 6 shows the average gloss values for each specimen at a 85° geometry. The graph of FIG. 6 also has standard deviation bars of ±σ centered on the average value. From this graph, it can be seen that there is little difference between the benchmark MCD D1060 drape material and the colored drape material. Once again, these materials have very similar surface texture. It is further clear from the graph of FIG. 6 that the gross values for the benchmark 3M® 1060 drape samples are higher than those of the benchmark MCD D1060 drape and colored drapes. Both samples of the benchmark 3M® 1060 drape have the same average gloss value (i.e., 4.9). The average gloss values for the samples of the benchmark MCD D1060 drape and colored drape materials are between 1.7 and 2.6. The clear MCD drape samples have values at both extremes of this range, and all the gloss values for the colored drapes fell between these two extremes, indicating that color was not a factor. Since the main difference between all of these materials is surface texture, it is apparent that the rougher (i.e., less smooth) surface finishes of the MCD D1060 and the colored drape materials reduce glare significantly when compared to the benchmark 3M® 1060. There seems to be no correlation between the color of the drape material and glare reduction since the gloss value difference between the benchmark MCD D1060 clear drape and the colored drapes is not very significant. [0035]
  • Results of a statistical analysis of gloss data are generally presented in FIGS. [0036] 7-10. Values for tabulated statistical parameters are found in FIG. 7, tabulated t-Test results for the MCD D1060 and 3M® 1060 drapes are found in FIG. 8., with mean and standard deviation gloss readings for noted test articles illustrated in FIGS. 9 and 10 respectively.
  • Illuminance and Chromaticity Testing [0037]
  • Illuminance and chromaticity testing was performed to measure the differences between the colored and clear drape materials. The illuminance test measures the amount of light that was reflected from the drapes' surface. The chromaticity test measures the hue and saturation of the light reflected from the surface. The tests were performed on the matte and non-matte finished sides of the drape materials. The test was performed using a PR-703 photo research spectra radiometer. The samples were placed in the same standard surface and a xenon light source was used to illuminate the material. The light source was perpendicular to the surface of the material. The detector was at a 10° angle from the light beam since it could not physically occupy the same space as the light source. [0038]
  • As the objective of the illuminance and chromaticity testing is to find the material colors that most reduce the intensity of reflected light, determination of luminance value (i.e., a measurement of luminous intensity of light being reflected from the surface of the material in a given direction per unit area of projected area of the source, as viewed from that direction) is critical. The results of the illuminance test are presented in FIGS. 11 and 12. [0039]
  • The results of this test indicate that there is a difference between the different drape material colors when it comes to the amount of light reflected. The wide standard deviation bars (±σ centered about the average value calculated from the data point on the graph) indicate this large difference. The highest value was for the benchmark 3M® 1060 drape. It had luminance values of 6,675 foot lambert (fL) on the matte side and 6,528 fL on the non-matte side. The benchmark MCD D1060 drape was also above the 6,000 fL value. The lowest values were associated with films colored red, dark blue, and purple (i.e., violet), with their luminance values ranging from 3,637 to 3,908 fL for the matte finish side of the film, and 3,624 to 3,790 fL for the non-matte side of the film. They were substantially lower than all other film colorations. From this information it is concluded that the intensity of the light reflected was lowest for the dark colors, and highest for the two benchmark drapes. This test also supports the notion that the color of the drape material plays a much great role in the intensity of the reflected light. The finish of the film has minimal effect on the intensity of reflected light, as shown by the very close values associated with the matte and non-matte finish sides of each of the films. On the graph of FIG. 12, the standard deviation bars of ±σ centered on the average value of all the data points for the matte and non-matte finish sides are indicated. The average for both is almost the same, and the standard deviation for both almost identical, indicating that the surface finish of the film does not affect the intensity of the reflected light. [0040]
  • The colored drape line testing indicates that the surface finish of the film has the greatest effect on glare. The rougher the surface finish, the less glare. Color has very negligible effect on glare. Furthermore, the color of the film has the greatest effect on the reduction of the intensity of the light reflected from the film surface. The darker colors, towards the red and violet ends of the spectrum, performed best. The colors in the middle of the visible spectrum did not perform as well, with the two white colored benchmark drapes being the least effective. The surface finish of the film had no effect on the amount of light reflected. In summary, the color of the film controls the intensity of the light reflected, and surface finish of the film controls the glare. [0041]
  • It will be understood that this disclosure, in many respects, is only illustrative. Changes may be made in details, particularly in matters of shape, size, material, and arrangement of parts without exceeding the scope of the invention. Accordingly, the scope of the invention is as defined in the language of the appended claims. [0042]

Claims (16)

What is claimed is:
1. A surgical drape comprising a polymeric film having a low glare finish and a predetermined coloration for reducing the luminous intensity of light reflected from the surface thereof, said surgical drape thereby minimizing reflectivity and potential eye strain.
2. The surgical drape of claim 1 wherein said energy absorbing polymeric film reflects light having a wavelength in the range of about 4,000 to 4,500 angstroms.
3. The surgical drape of claim 1 wherein said energy absorbing polymeric film reflects light having a wavelength in the range of about 4,500 to 5,200 angstroms.
4. The surgical drape of claim 1 wherein said energy absorbing polymeric film reflects light having a wavelength in the range of about 5,200 to 5,600 angstroms.
5. The surgical drape of claim 1 wherein said energy absorbing polymeric film reflects light having a wavelength in the range of about 6,250 to 7,000 angstroms.
6. The surgical drape of claim 1 wherein said low glare finish is a matted surface.
7. The surgical drape of claim 1 wherein said low glare finish is a textured surface.
8. The surgical drape of claim 1 wherein said luminous intensity is reduced by up to about 45%.
9. The surgical drape of claim 1 wherein said polymeric film comprises a polyolefin.
10. The surgical drape of claim 1 further comprising a coating of an adhesive composition overlying at least a portion of said polymeric film.
11. The surgical drape of claim 10 further comprising a release liner, said release liner overlaying said coating of an adhesive composition for selective removal therefrom.
12. The surgical drape of claim 11 further comprising an antimicrobial agent carried by said polymeric film, said antimicrobial agent being carried by said polymeric film on a side opposite said coating of an adhesive composition.
13. In a method of producing a surgical drape, the steps comprising:
(a) selectively adding coloration to a polymeric drape starting material;
(c) forming a surgical drape from the colored polymeric drape starting material so as to produce a translucent, energy absorbing polymeric surgical drape capable of reducing the luminous intensity of light being reflected from the surface thereof, thereby substantially eliminating eye strain.
14. In the method of claim 13, the further step of providing a low glare finish to at least one side of said translucent, energy absorbing polymeric surgical drape.
15. In the method of claim 14 wherein said low glare finish is a matted surface.
16. In the method of claim 14 wherein said low glare finish is a textured surface.
US10/385,981 2001-10-10 2003-03-10 Minimally light reflective surgical drape Abandoned US20040003818A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US09/975,646 US6530376B1 (en) 2001-10-10 2001-10-10 Minimally light reflective surgical drape
US10/385,981 US20040003818A1 (en) 2001-10-10 2003-03-10 Minimally light reflective surgical drape

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/385,981 US20040003818A1 (en) 2001-10-10 2003-03-10 Minimally light reflective surgical drape
US11/672,824 US20070125389A1 (en) 2001-10-10 2007-02-08 Minimally light reflective surgical drape
US11/752,107 US20080078413A1 (en) 1996-06-12 2007-05-22 Surgical drape

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US09/975,646 Continuation US6530376B1 (en) 2001-10-10 2001-10-10 Minimally light reflective surgical drape

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US11/672,824 Continuation US20070125389A1 (en) 2001-10-10 2007-02-08 Minimally light reflective surgical drape

Publications (1)

Publication Number Publication Date
US20040003818A1 true US20040003818A1 (en) 2004-01-08

Family

ID=25523245

Family Applications (3)

Application Number Title Priority Date Filing Date
US09/975,646 Active US6530376B1 (en) 2001-10-10 2001-10-10 Minimally light reflective surgical drape
US10/385,981 Abandoned US20040003818A1 (en) 2001-10-10 2003-03-10 Minimally light reflective surgical drape
US11/672,824 Abandoned US20070125389A1 (en) 2001-10-10 2007-02-08 Minimally light reflective surgical drape

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US09/975,646 Active US6530376B1 (en) 2001-10-10 2001-10-10 Minimally light reflective surgical drape

Family Applications After (1)

Application Number Title Priority Date Filing Date
US11/672,824 Abandoned US20070125389A1 (en) 2001-10-10 2007-02-08 Minimally light reflective surgical drape

Country Status (7)

Country Link
US (3) US6530376B1 (en)
JP (2) JP4511781B2 (en)
AU (1) AU2002301402B2 (en)
CA (1) CA2407216A1 (en)
IL (1) IL152191A (en)
NZ (1) NZ521897A (en)
ZA (1) ZA200208173B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040030341A1 (en) * 2001-03-02 2004-02-12 Marcel Aeschlimann Implants, device and method for joining tissue parts
WO2006105061A2 (en) * 2005-03-25 2006-10-05 Myers Surgical Solutions, Llc Conformable drape system

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6530376B1 (en) * 2001-10-10 2003-03-11 Medical Concepts Development, Inc. Minimally light reflective surgical drape
US7290547B2 (en) * 2003-12-01 2007-11-06 Joseph Hare Covering for an aseptic treatment site
US7275544B2 (en) * 2003-12-01 2007-10-02 Michael Gil Covering for an aseptic treatment site
EP1907751A4 (en) * 2005-07-20 2010-11-24 Optimus Services Llc In-ceiling focus located surgical lighting

Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3589365A (en) * 1969-08-28 1971-06-29 Parke Davis & Co Underbuttocks drape
US3668050A (en) * 1970-03-09 1972-06-06 Kimberly Clark Co Surgical drape
US3669106A (en) * 1970-07-27 1972-06-13 Kimberly Clark Co Surgical drape with adhesive attachment means
US3677266A (en) * 1970-12-31 1972-07-18 Kimberly Clark Co Gauze section for a surgical drape sheet
US3763857A (en) * 1972-04-24 1973-10-09 Kimberly Clark Co Surgical drape
US4196245A (en) * 1978-06-16 1980-04-01 Buckeye Cellulos Corporation Composite nonwoven fabric comprising adjacent microfine fibers in layers
US4408996A (en) * 1981-10-09 1983-10-11 Burlington Industries, Inc. Process for dyeing absorbent microbiocidal fabric and product so produced
US5069907A (en) * 1990-03-23 1991-12-03 Phoenix Medical Technology Surgical drape having incorporated therein a broad spectrum antimicrobial agent
US5503076A (en) * 1993-12-01 1996-04-02 Kimberly-Clark Corporation Multi-color printed nonwoven laminates
US5985395A (en) * 1996-05-16 1999-11-16 3M Innovative Properties Company Surgical incise drape

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5225236A (en) * 1989-06-28 1993-07-06 Preston Keusch Composite protective drapes
JP3221649B2 (en) * 1995-09-18 2001-10-22 ユニチカ株式会社 Medical laminated fabrics
US6165625A (en) * 1996-12-19 2000-12-26 Kimberly-Clark Worldwide, Inc. Method of making high intensity light resistant instrument pads
US6245697B1 (en) * 1998-11-12 2001-06-12 The Procter & Gamble Company Flexible mat for absorbing liquids comprising polymeric foam materials
JP4364344B2 (en) * 1999-05-10 2009-11-18 ユニチカ株式会社 Medical laminated fabrics
US6638605B1 (en) * 1999-11-16 2003-10-28 Allegiance Corporation Intermittently bonded nonwoven disposable surgical laminates
WO2001054641A1 (en) * 2000-01-31 2001-08-02 Bki Holding Corporation Absorbent products with improved vertical wicking and rewet capability
US6530376B1 (en) * 2001-10-10 2003-03-11 Medical Concepts Development, Inc. Minimally light reflective surgical drape

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3589365A (en) * 1969-08-28 1971-06-29 Parke Davis & Co Underbuttocks drape
US3668050A (en) * 1970-03-09 1972-06-06 Kimberly Clark Co Surgical drape
US3669106A (en) * 1970-07-27 1972-06-13 Kimberly Clark Co Surgical drape with adhesive attachment means
US3677266A (en) * 1970-12-31 1972-07-18 Kimberly Clark Co Gauze section for a surgical drape sheet
US3763857A (en) * 1972-04-24 1973-10-09 Kimberly Clark Co Surgical drape
US4196245A (en) * 1978-06-16 1980-04-01 Buckeye Cellulos Corporation Composite nonwoven fabric comprising adjacent microfine fibers in layers
US4408996A (en) * 1981-10-09 1983-10-11 Burlington Industries, Inc. Process for dyeing absorbent microbiocidal fabric and product so produced
US5069907A (en) * 1990-03-23 1991-12-03 Phoenix Medical Technology Surgical drape having incorporated therein a broad spectrum antimicrobial agent
US5503076A (en) * 1993-12-01 1996-04-02 Kimberly-Clark Corporation Multi-color printed nonwoven laminates
US5985395A (en) * 1996-05-16 1999-11-16 3M Innovative Properties Company Surgical incise drape

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040030341A1 (en) * 2001-03-02 2004-02-12 Marcel Aeschlimann Implants, device and method for joining tissue parts
WO2006105061A2 (en) * 2005-03-25 2006-10-05 Myers Surgical Solutions, Llc Conformable drape system
WO2006105061A3 (en) * 2005-03-25 2007-03-29 Myers Surgical Solutions Llc Conformable drape system

Also Published As

Publication number Publication date
IL152191D0 (en) 2003-05-29
ZA200208173B (en) 2003-10-23
IL152191A (en) 2007-10-31
NZ521897A (en) 2004-04-30
JP4511781B2 (en) 2010-07-28
US6530376B1 (en) 2003-03-11
CA2407216A1 (en) 2003-04-10
JP2003199769A (en) 2003-07-15
US20070125389A1 (en) 2007-06-07
AU2002301402B2 (en) 2009-06-11
JP2010022841A (en) 2010-02-04

Similar Documents

Publication Publication Date Title
Fondriest Shade matching in restorative dentistry: the science and strategies
US5400175A (en) Ultraviolet radiation and blue light blocking polarizing lens
Delori Spectrophotometer for noninvasive measurement of intrinsic fluorescence and reflectance of the ocular fundus
Berns Billmeyer and Saltzman's principles of color technology
Bone et al. Comparison of macular pigment densities in human eyes
JP3246604B2 (en) The method of manufacturing the optical means and optical means for color vision improvement or change
US20030067545A1 (en) Device and method for acquiring an image of a portion of the human body
US20150064123A1 (en) High energy visible light filter systems with yellowness index values
Sikri Color: Implications in dentistry
Hammond Jr et al. Assessment of the validity of in vivo methods of measuring human macular pigment optical density
Bruno et al. Lightness, equivalent backgrounds, and anchoring
He et al. A system of mesopic photometry
Abramov et al. Color vision in the peripheral retina. I. Spectral sensitivity
He et al. Evaluating light source efficacy under mesopic conditions using reaction times
US6315412B1 (en) Method and apparatus for measuring visual sensitivity and optical properties of components of the eye
Tansley et al. Chromatic border perception: the role of red-and green-sensitive cones
Brindley et al. The reflexion of light from the macular and peripheral fundus oculi in man
EP0292475B1 (en) Ultraviolet radiation and blue light blocking polarizing lens
Hammond et al. Individual variations in the spatial profile of human macular pigment
JP4464726B2 (en) Ophthalmic apparatus
US7400754B2 (en) Method and apparatus for characterization of chromophore content and distribution in skin using cross-polarized diffuse reflectance imaging
JP5548754B2 (en) Color regulating device, a method of color temperature adjustment facilities and color temperature adjustment using it
Van Der Veen et al. A new desktop instrument for measuring macular pigment optical density based on a novel technique for setting flicker thresholds
US6963399B2 (en) Method and apparatus for quantifying an “integrated index” of a material medium
Lightstone et al. Both coloured overlays and coloured lenses can improve reading fluency, but their optimal chromaticities differ

Legal Events

Date Code Title Description
STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION